Mink Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $3,769,421 | $0 |
Gross Profit | -48 | -50 | 1,884,710 | -1,884,612 |
EBITDA | -4,188 | -2,715 | -2,161 | -1,821 |
EBIT | -4,237 | -2,766 | -2,214 | -1,884 |
Net Income | -4,237 | -2,766,697 | -2,463 | -1,806 |
Net Change In Cash | 0 | 0 | 3,769,421 | 0 |
Free Cash Flow | -1,569 | -1,340,876 | -1,727 | -2,994 |
Cash | 1,681 | 3,234 | 4,577 | 6,328 |
Basic Shares | 3,981 | 3,964 | 3,773 | 3,953 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $2,704,743 | $0 |
Gross Profit | -215 | -204 | -28,244,535 | -77 |
EBITDA | -10,569 | -22,253 | -30,827 | -27,703 |
EBIT | -10,784 | -22,457 | -30,949 | -27,781 |
Net Income | -10,784 | -22,457 | -27,991 | -30,212 |
Net Change In Cash | 0 | 0 | 2,704,743 | 0 |
Cost of Revenue | -19,272 | |||
Free Cash Flow | -9,555 | -15,836 | -19,116 | -13,076 |
Cash | 4,577 | 3,367 | 19,635 | 38,888 |
Basic Shares | 3,863 | 3,435 | 3,367 | 3,347 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$1.06 |
2025-03-31 | -$0.70 |
2024-12-31 | -$0.62 |
2024-09-30 | -$0.05 |
